All In Biotech

Drug Trial Radar · NCT00883558

Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus

A Phase II, Randomized, Open Label, 2-Way Crossover, Safety Study of Subcutaneously Injected Prandial INSULIN-PH20 NP Compared to Insulin Analog Injection in Patients With Type 1 Diabetes

Last checked: Nov 20, 2026Latest source record: Sep 8, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

48

Actual

Start

May 2009

Primary completion

Feb 2010

Study completion Apr 2010

Sponsor

Lead sponsor
Halozyme TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 17, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
None
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Insulin lispro is approved by the Food and Drug Administration (FDA) for the treatment of diabetes mellitus. Recombinant human hyaluronidase (rHuPH20) is approved by the FDA as an aid to the absorption and dispersion of other injectable drugs. In this study, rHuPH20 combined with a non-preserved (NP) formulation of regular human insulin (INSULIN-PH20 NP) will be compared to insulin lispro with respect to absorption and action of insulin.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • Insulin LisproDrug

  • regular human insulinDrug

  • recombinant human hyaluronidase PH20Drug

  • Insulin glargineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Postprandial Glucose ExcursionTime frame: Week 14 and Week 26

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Barbara Davis Center for Childhood Diabetes

    Aurora, Colorado

  • Diabetes Research Institute

    Miami, Florida

  • Henry Ford Health System

    Detroit, Michigan

  • Mercury Street Medical

    Butte, Montana

  • UNC Diabetes Care Center/Highgate Specialty Center

    Durham, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Texas Diabetes and Endocrinology

    Austin, Texas

  • West Olympia Internal Medicine

    Olympia, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.